loader
Please Wait
Applying Filters...
menu
    • menu

    Setid 992306f0 C612 41dd A4df 35d1fd360033 Applno 20705 Form Tablet Oral Dosage 200mg - Drug Product Composition: Delavirdine

    Menu

    Delavirdine

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 20705 / DOSAGE - TABLET;ORAL - 200MG

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    DELAVIRDINE MESYLATE(UNII: 421105KRQE)
    (DELAVIRDINE - UNII:DOL5F9JD3E)     		DELAVIRDINE MESYLATE200mg

    Inactive Ingredients

    Ingredient Name
    KAISER FOUNDATION HOSPITALS
    ViiV Healthcare Company
    ANHYDROUS LACTOSE(3SY5LH9PMK)
    CARNAUBA WAX(R12CBM0EIZ)
    CROSCARMELLOSE SODIUM(M28OL1HH48)
    HYPROMELLOSE, UNSPECIFIED(3NXW29V3WO) 
    HYPROMELLOSES(3NXW29V3WO) 
    MAGNESIUM STEARATE(70097M6I30)
    MICROCRYSTALLINE CELLULOSE(OP1R32D61U)
    SILICON DIOXIDE(ETJ7Z6XBU4)